Zimmer Biomet SVP awarded 7,880 RSUs

Zimmer Biomet Holdings, Inc. senior vice president and chief human resources officer Lori Winkler reported equity compensation activity involving restricted stock units (RSUs) and common stock.

Rhea-AI Filing Summary

Zimmer Biomet Holdings, Inc. senior vice president and chief human resources officer Lori Winkler reported equity compensation activity involving restricted stock units (RSUs) and common stock. On February 20, 2026, 1,845 RSUs were converted into 1,845 shares of common stock, and she received a new grant of 7,880 RSUs. According to the disclosure, each RSU represents a contingent right to receive one share of company common stock, and the new grant vests annually over three years in one-third increments starting February 20, 2027. The filing also shows 683 shares of common stock were withheld by the company at $98.62 per share to satisfy tax withholding obligations related to the RSU vesting.

Insider Trade Summary

1,845 shares exercised/converted

Exercise 4 txns

Insider Winkler Lori

Role SVP and CHRO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,845	$0.00	$0.00
Grant/Award	Restricted Stock Units	7,880	$0.00	$0.00
Exercise	Common Stock	1,845	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	683	$98.62	$67K

Holdings After Transaction: Restricted Stock Units — 9,724 contracts (Direct); Common Stock — 7,995 shares (Direct)

Footnotes (3)

1. F1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
2. F2. Each RSU represents a contingent right to receive one share of Company common stock.
3. F3. Vests annually over three years in increments of one-third each year, commencing February 20, 2027.

FAQ

What did Lori Winkler report in the latest Form 4 for ZBH?

Lori Winkler reported RSU vesting, a new RSU grant, and related tax withholding. 1,845 RSUs converted into common shares, she received 7,880 new RSUs, and 683 shares were withheld to cover taxes at $98.62 per share.

How many restricted stock units were granted to Lori Winkler at ZBH?

Lori Winkler was granted 7,880 restricted stock units. Each RSU represents a contingent right to receive one share of Zimmer Biomet common stock, providing equity-based compensation tied directly to the company’s share price performance over time.

What is the vesting schedule for Lori Winkler’s new ZBH RSU award?

The 7,880 restricted stock units vest annually over three years. The award vests in one-third increments each year, beginning on February 20, 2027, aligning executive compensation with longer-term company performance and retention objectives.

How many ZBH shares were withheld to cover Lori Winkler’s taxes?

Zimmer Biomet withheld 683 shares of common stock to satisfy Lori Winkler’s tax withholding obligations. These shares were valued at $98.62 per share, and the withholding relates specifically to the vesting of restricted stock units on February 20, 2026.

What does each ZBH restricted stock unit represent for Lori Winkler?

Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet common stock. This means Lori Winkler’s RSUs only convert into actual shares as they vest according to the specified three-year vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 09:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Winkler Lori

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW IN 46580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and CHRO

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		M		1,845	A	$0	8,678	D
Common Stock	02/20/2026		F		683(1)	D	$98.62	7,995	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	02/20/2026		M			1,845	02/20/2026	02/20/2026	Common Stock	1,845	$0	1,844	D
Restricted Stock Units	(2)	02/20/2026		A		7,880		(3)	(3)	Common Stock	7,880	$0	7,880	D

Explanation of Responses:

1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

2. Each RSU represents a contingent right to receive one share of Company common stock.

3. Vests annually over three years in increments of one-third each year, commencing February 20, 2027.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Lori Winkler (power of attorney previously filed)	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.